Pfizer-BioNTech inoculation may have broader effects on the immune system, helping to reduce inflammation in a way similar to ...

Researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended, primary target. They ...

Strand Therapeutics Inc., the programmable mRNA company developing curative therapies for cancer and beyond, will present preclinical data from its STX-003 program at the 2025 annual meetings of the ...

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...

While mRNA vaccines represent a transformative platform for infectious disease control, their efficacy in antigen-presenting cells (APCs) remains vulnerable to endogenous regulatory networks, ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

In this webinar, Benoit Derrien will discuss new strategies using enzymatically synthesized DNA for gene construction.

Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for ...